AI assistant
DIMERIX LIMITED — Capital/Financing Update 2012
Dec 16, 2012
64804_rns_2012-12-16_705d216e-caf0-459d-a287-60e23723060b.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [234 x 86] intentionally omitted <==
17 December 2012
The Manager Company Announcements Platform ASX Limited
SBN Rights Issue – Allotment of entitlement shares
Sun Biomedical Limited (ASX: SBN) advises that 34,203,174 fully paid, ordinary shares in the Company were allotted on 14 December 2012 pursuant to the Company’s fully underwritten, nonrenounceable rights issue announced on 9 November 2012. The shortfall securities are expected to be allotted by 21 December 2012.
The total number of shares in the Company on issue following the allotment of entitlement shares on 14 December 2012 is 199,773,178. The total number of shares on issue following allotment of shortfall securities will be 331,140,008.
Yours faithfully
==> picture [112 x 19] intentionally omitted <==
==> picture [112 x 19] intentionally omitted <==
Alfonso Grillo Company Secretary
Sun Biomedical Investor Communications Limited Computershare T: +61 1300 850 505 | F: +61 3 9473 2500
ASX:SBN www.sunbiomed.com
==> picture [66 x 6] intentionally omitted <==
----- Start of picture text ----- ABN 18 001 285 230----- End of picture text -----